Funding for this research was provided by:
the National Key Technology R&D Program for the 12th Five-year Plan of Ministry of Science and Technology, China (2013BAI02B03)
Traditional Chinese Medicine Bureau Foundation of Guangdong Province (20161111, 20183005)
Received: 14 November 2017
Accepted: 27 May 2019
First Online: 17 June 2019
Ethics approval and consent to participate
: This research protocol had been reviewed and approved by the institutional review boards of both trial centers (GPHCM and Guangzhou Red Cross Hospital; B2012-55-01). Important protocol modifications will be immediately communicated to the GPHCM Ethics Committee and Data Monitoring Committee by amendments. All modifications will also be updated on the Chinese Clinical Trial Registry.The data and findings will be disseminated to the public through patient associations, conference presentations, and open-access journals. The aggregated data will also be shared with the public through the Chinese Clinical Trial Registry.Written informed consent will be obtained from all eligible patients before the enrollment and then taken by the treating clinician.
: Not applicable.
: The authors declare that they have no competing interests.